Bluebird stock soars on FDA committee news, despite overall market woes


Shares of bluebird bio Inc. rose substantially after a double endorsement by a key FDA advisory committee, despite overall market woes.

Previous Research by Cleveland behavioral health expert sheds light on substance abuse disorders and inequitable treatment among people of color
Next Raleigh area restaurants that missed the mark on heath inspections